XML 14 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 31, 2016
Oct. 31, 2015
Net income including noncontrolling interests $ 23,969 $ 32,583
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, impairment charges and amortization 14,567 14,193
Income from equity method investments (3,257) (7,857)
Gain on disposal of real estate and property and equipment, net (364) (496)
Dividends received from equity method investees 4,010 7,643
Gain on sale of investment (192) (10,385)
Deferred income tax (1,019) (8,078)
Stock based compensation expense 68 23
Changes in assets and liabilities:    
Accounts receivable (1,686) (2,307)
Inventories (2,305) (5,494)
Other assets 2,758 (51)
Accounts payable, trade 1,653 4,913
Other liabilities 3,157 (2,849)
Net cash provided by operating activities 41,359 21,838
Cash flows from investing activities:    
Capital expenditures (11,836) (9,852)
Restricted cash 8 (20)
Restricted investments and deposits 460 250
Proceeds from sale of investment 2,275 45,476
Proceeds from sale of real estate and property and equipment, net 1,510 1,936
Other 17 17
Net cash (used in) provided by investing activities (7,566) 37,807
Cash flows from financing activities:    
Dividend payments to and purchases of stock from noncontrolling interests holders (2,096) (605)
Treasury stock acquired (4,709) (60,111)
Net cash used in financing activities (6,805) (60,716)
Net increase (decrease) in cash and cash equivalents 26,988 (1,071)
Cash and cash equivalents, beginning of period 135,765 137,697
Cash and cash equivalents, end of period 162,753 136,626
Non cash investing activities – Accrued capital expenditures 1,183 $ 1,216
Non cash financing activities – Equity awards issued $ 1,095